+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
H1N1 Vaccines Market - Global Forecast 2026-2032- Product Image
H1N1 Vaccines Market - Global Forecast 2026-2032- Product Image
New

H1N1 Vaccines Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904545
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The H1N1 Vaccines Market continues to evolve as new technologies and shifting regulatory landscapes redefine how public health systems, biopharma manufacturers, and procurement leaders navigate vaccine development and distribution. Senior decision-makers must maintain agility and build strategic frameworks that foster collaboration and operational resilience within this complex ecosystem.

Market Snapshot: Growth Trajectory in the H1N1 Vaccines Market

The H1N1 Vaccines Market is experiencing rapid expansion, growing from USD 18.32 billion in 2025 to USD 24.96 billion in 2026. With a compound annual growth rate (CAGR) of 36.56%, the market is projected to reach USD 162.32 billion by 2032. This robust upward trajectory reflects rising global demand, development of advanced platform technologies, and increasing regulatory engagement. Senior leadership in manufacturing, supply chain, and procurement must consistently monitor these market forces to capitalize on emerging opportunities as the landscape continues to evolve.

Scope & Segmentation of the Global H1N1 Vaccines Market

  • Product Types: Inactivated vaccine varieties—including cell-based, egg-based, and recombinant forms—together with live attenuated vaccines, are designed for diverse immunization scenarios and patient requirements.
  • Technology Platforms: Incorporates cell-based methods for adaptive scalability, egg-based approaches for established immunogenicity, and recombinant processes that drive product innovation and transform vaccine life cycles.
  • Dosage Formats: Options like multi-dose vials and pre-filled syringes enable flexibility for both high-throughput clinics and point-of-care applications, streamlining delivery and patient management.
  • Age Cohorts: Targets adults, children, and seniors, each group supported by differentiated protocols to optimize immunogenicity and ensure safety across different immune profiles.
  • Distribution Channels: Includes hospitals, public health centers, clinics, hospital pharmacies, retail pharmacies, and online pharmacies, each requiring tailored storage and cold-chain management for effective vaccine dissemination and compliance.
  • Geographical Regions: Covers the Americas; Europe, Middle East & Africa (EMEA); and Asia-Pacific. Each region introduces unique regulatory frameworks, supply chain requirements, and deployment challenges, requiring adaptable approaches across diverse markets.

Key Takeaways for Senior Decision-Makers

  • Flexibility in manufacturing operations and robust supply chain strategies are essential for adapting to disruptions, optimizing output, and maintaining continuity across global markets.
  • Collaboration between manufacturers, regulatory authorities, and public health entities is becoming increasingly important as regulatory pathways shift and new response models are adopted.
  • Differentiated approaches to packaging and dosage selection enable alignment with specific clinical needs, supporting diverse patient populations and operational settings.
  • The effectiveness of vaccine rollout directly correlates with the maturity and reliability of distribution channels, with cold-chain integrity impacting patient adherence and trust.
  • Adaptability in supply models is critical to accommodate variable purchasing structures and regulatory requirements across multiple regions.
  • Ongoing post-market monitoring and pharmacovigilance reinforce transparency and credibility, meeting both payer expectations and evolving regulatory standards.

Tariff Impact on Sourcing Strategies

Following United States tariff policies implemented in 2025, vaccine manufacturers and buyers have increased focus on nearshoring and localized production capabilities. Supplier portfolios are regularly evaluated to enhance reliability, while procurement emphasizes consistent supply, delivery stability, and risk mitigation. Onshore fill-finish processes and greater digitization support compliance and help to address operational volatility. Public health agencies are adapting contracting approaches to secure uninterrupted vaccine access despite dynamic trade circumstances.

Methodology & Data Sources

The research draws from in-depth interviews with industry executives, distribution partners, regulatory specialists, and frontline clinical staff. Analysis is further informed by peer-reviewed publications, regulatory records, and procurement documentation. Scenario mapping and benchmarking validate findings, ensuring clarity and reliability for senior stakeholders.

Why This Report Matters

  • Offers clear segmentation insights, empowering targeted product positioning, supply chain decisions, and effective channel strategies in key markets.
  • Equips senior leadership with evidence-based guidance for maintaining operational continuity and regulatory alignment while supporting global or regional expansion plans.
  • Integrates critical data on technological innovation, regulatory adaptation, and geographic diversification to enable risk-aware decision-making in a changing landscape.

Conclusion

Success in the H1N1 Vaccines Market is grounded in adaptive strategies, data-driven decision-making, and cross-functional alignment. Senior leaders who prioritize these elements will be well-positioned to navigate shifting public health and regulatory environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. H1N1 Vaccines Market, by Product Type
8.1. Inactivated Vaccine
8.1.1. Cell Based
8.1.2. Egg Based
8.1.3. Recombinant
8.2. Live Attenuated Vaccine
9. H1N1 Vaccines Market, by Technology
9.1. Cell Based
9.2. Egg Based
9.3. Recombinant
10. H1N1 Vaccines Market, by Dosage Form
10.1. Multi-Dose Vials
10.2. Pre-Filled Syringes
11. H1N1 Vaccines Market, by Age Group
11.1. Adults
11.2. Children
11.3. Seniors
12. H1N1 Vaccines Market, by End User
12.1. Clinics
12.2. Hospitals
12.3. Public Health Centers
13. H1N1 Vaccines Market, by Distribution Channel
13.1. Hospital Pharmacies
13.2. Online Pharmacies
13.3. Retail Pharmacies
14. H1N1 Vaccines Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. H1N1 Vaccines Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. H1N1 Vaccines Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States H1N1 Vaccines Market
18. China H1N1 Vaccines Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Astellas Pharma Inc.
19.7. AstraZeneca PLC
19.8. Bavarian Nordic A/S
19.9. Bharat Biotech Ltd.
19.10. Biological E. Limited
19.11. BioNTech SE
19.12. Blue Lake Biotechnology
19.13. Capricor Therapeutics, Inc.
19.14. Chongqing Zhifei Biological Products Co., Ltd.
19.15. CSL Limited
19.16. CureVac N.V.
19.17. Daiichi Sankyo Company, Limited.
19.18. Gennova Biopharmaceuticals Limited
19.19. GlaxoSmithKline PLC
19.20. Haffkine Bio-Pharmaceutical Corporation Ltd.
19.21. Incepta Pharmaceuticals Ltd.
19.22. Inovio Pharmaceuticals, Inc.
19.23. Johnson & Johnson Services, Inc.
19.24. Merck & Co., Inc.
19.25. Moderna, Inc.
19.26. Novavax, Inc.
19.27. Pfizer Inc.
19.28. Sanofi S.A.
List of Figures
FIGURE 1. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL H1N1 VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL H1N1 VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES H1N1 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA H1N1 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL H1N1 VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL H1N1 VACCINES MARKET SIZE, BY CELL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL H1N1 VACCINES MARKET SIZE, BY EGG BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL H1N1 VACCINES MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL H1N1 VACCINES MARKET SIZE, BY MULTI-DOSE VIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL H1N1 VACCINES MARKET SIZE, BY MULTI-DOSE VIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL H1N1 VACCINES MARKET SIZE, BY MULTI-DOSE VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL H1N1 VACCINES MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL H1N1 VACCINES MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL H1N1 VACCINES MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL H1N1 VACCINES MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL H1N1 VACCINES MARKET SIZE, BY CHILDREN, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL H1N1 VACCINES MARKET SIZE, BY CHILDREN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL H1N1 VACCINES MARKET SIZE, BY CHILDREN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL H1N1 VACCINES MARKET SIZE, BY SENIORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL H1N1 VACCINES MARKET SIZE, BY SENIORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL H1N1 VACCINES MARKET SIZE, BY SENIORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL H1N1 VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL H1N1 VACCINES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL H1N1 VACCINES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL H1N1 VACCINES MARKET SIZE, BY PUBLIC HEALTH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL H1N1 VACCINES MARKET SIZE, BY PUBLIC HEALTH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL H1N1 VACCINES MARKET SIZE, BY PUBLIC HEALTH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL H1N1 VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL H1N1 VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL H1N1 VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL H1N1 VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS H1N1 VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. EUROPE H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 101. EUROPE H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 103. EUROPE H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 104. EUROPE H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 105. EUROPE H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. EUROPE H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. AFRICA H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. AFRICA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 117. AFRICA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 118. AFRICA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. AFRICA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 120. AFRICA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 121. AFRICA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. AFRICA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL H1N1 VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. ASEAN H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 135. ASEAN H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. ASEAN H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 137. ASEAN H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 138. ASEAN H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. ASEAN H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. GCC H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GCC H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. GCC H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 143. GCC H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 144. GCC H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 145. GCC H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 146. GCC H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. GCC H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. BRICS H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. BRICS H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. BRICS H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 159. BRICS H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. BRICS H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 161. BRICS H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 162. BRICS H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. BRICS H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. G7 H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. G7 H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 166. G7 H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 167. G7 H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. G7 H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 169. G7 H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 170. G7 H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. G7 H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. NATO H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. NATO H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 174. NATO H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 175. NATO H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. NATO H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 177. NATO H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 178. NATO H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. NATO H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL H1N1 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES H1N1 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. UNITED STATES H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 184. UNITED STATES H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 186. UNITED STATES H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. CHINA H1N1 VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 190. CHINA H1N1 VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. CHINA H1N1 VACCINES MARKET SIZE, BY INACTIVATED VACCINE, 2018-2032 (USD MILLION)
TABLE 192. CHINA H1N1 VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 193. CHINA H1N1 VACCINES MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 194. CHINA H1N1 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 195. CHINA H1N1 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. CHINA H1N1 VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this H1N1 Vaccines market report include:
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech Ltd.
  • Biological E. Limited
  • BioNTech SE
  • Blue Lake Biotechnology
  • Capricor Therapeutics, Inc.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • CSL Limited
  • CureVac N.V.
  • Daiichi Sankyo Company, Limited.
  • Gennova Biopharmaceuticals Limited
  • GlaxoSmithKline PLC
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Incepta Pharmaceuticals Ltd.
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Sanofi S.A.

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 24.96 Billion
Forecasted Market Value ( USD ) by 2032 $ 162.32 Billion
Compound Annual Growth Rate36.5%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

H1N1 Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

H1N1 Vaccine Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
H1N1 Vaccine Market Report 2025 - Product Image

H1N1 Vaccine Market Report 2025

  • Report
  • 250 Pages
  • Global
From
H1N1 Vaccines - Global Strategic Business Report - Product Image

H1N1 Vaccines - Global Strategic Business Report

  • Report
  • 268 Pages
  • Global
From
H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2025-2033 - Product Image

H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From

About the H1N1 Vaccine Market

The H1N1 Vaccine is a vaccine developed to protect against the H1N1 strain of influenza, also known as swine flu. It is a type of inactivated vaccine, meaning it contains killed virus particles that are unable to cause infection. The vaccine is administered through injection and is recommended for people of all ages. It is especially important for those at high risk of complications from the virus, such as pregnant women, young children, and people with weakened immune systems. The H1N1 Vaccine market is a subset of the larger Vaccines market, which includes a wide range of products designed to protect against infectious diseases. Vaccines are an important tool in public health, as they can help reduce the spread of disease and protect vulnerable populations. Some companies in the H1N1 Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck, and Pfizer. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.